Classification
Compound class	Peptide or derivative
Approved drug?	Yes (source: FDA and EMA (2000))

International Nonproprietary Names
INN number	INN
7548	insulin glargine

Synonyms

HOE-901

HOE901

Lantus®

Database Links
CAS Registry No.	160337-95-1
ChEMBL Ligand	CHEMBL1201497
DrugBank Ligand	DB00047
PubChem CID	44146714
Search PubMed clinical trials	insulin glargine
Search PubMed titles	insulin glargine
Search PubMed titles/abstracts	insulin glargine
Wikipedia	Insulin glargine

Comments

Insulin glargine is a recombinant, modified analogue of human insulin. A fixed-ratio formulation containing insulin glargine and lixisenatide is being assessed in clinical trials for the treatment of type 2 diabetes. Click here to view a list of such trials registered with ClinicalTrials.gov. Biosimilar drugs: Insulin glargine biosimilar SB9 is in development by Samsung Bioepis